Recent Articles

Mylan NV (MYL) to Reduce EpiPen Price Amid Outcry

Mylan (MYL) has announced that it is working to reduce the price of the EpiPen after backlash from customers and government officials. More 

Mylan NV (MYL): Stop Rewarding Big Pharma Greed!

Mylan's (MYL) pricing of EpiPens may be the least among a host of scandals that have plagued Big Pharama this decade. More 

3 Big Stock Charts: Mylan NV (MYL), GoPro Inc (GPRO) and Goldman Sachs Group Inc (GS)

The market continues to slow, but Mylan (MYL), GoPro (GPRO) and Goldman Sachs (GS) are sending signals that they're all ready to move higher. More 

Stocks Weaker After Biotechs Battered

In the end, the Dow Jones lost 0.4%, the S&P 500 lost 0.5%, the Nasdaq lost 0.8% and the Russell 2000 finished the day down 0.9%. More 

Why J M Smucker Co (SJM), Mylan NV (MYL) and Zoe’s Kitchen Inc (ZOES) Are 3 of Today’s Worst Stocks

J M Smucker (SJM), Mylan NV (MYL) and Zoe's Kitchen (ZOES) were doomed from the start of today's trading. More 

EpiPen Outrage: Mylan NV (MYL) Hasn’t Learned Squat

Mylan (MYL) is under the microscope of the U.S. Senate Judiciary Committee over EpiPen pricing, and Mylan stock is suffering. This could have been avoided. More 

10 Healthcare Innovations That Will Change the World

Lots of companies are developing impressive, novel drugs and biotechnologies, but these healthcare outfits are close to reshaping how we view and think of health. More